Volumetry of Mesiotemporal Structures Reflects Serostatus in Patients with Limbic Encephalitis

References

1. 1.↵
   1. Bien CG,
   2. Elger CE.

   Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2007;10:529–38 doi:10.1016/j.yebeh.2007.03.011 pmid:17493878

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Dalmau J,
   2. Graus F.

   Antibody-mediated encephalitis. N Engl J Med 2018;378:840–51 doi:10.1056/NEJMra1708712 pmid:29490181

   CrossRefPubMed
3. 3.↵
   1. Graus F,
   2. Titulaer MJ,
   3. Balu R, et al

   . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404 doi:10.1016/S1474-4422(15)00401-9 pmid:26906964

   CrossRefPubMed
4. 4.↵
   1. Malter MP,
   2. Helmstaedter C,
   3. Urbach H, et al

   . Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470–78 doi:10.1002/ana.21917 pmid:20437582

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Binks SNM,
   2. Klein CJ,
   3. Waters P, et al

   . LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 2018;89:526–34 doi:10.1136/jnnp-2017-315720 pmid:29055902

   Abstract/FREE Full Text
6. 6.↵
   1. Dubey D,
   2. Pittock SJ,
   3. Kelly CR, et al

   . Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 2018;83:166–77 doi:10.1002/ana.25131 pmid:29293273

   CrossRefPubMed
7. 7.↵
   1. Van Sonderen A,
   2. Ariño H,
   3. Petit-Pedrol M, et al

   . The clinical spectrum of Caspr2 antibody-associated disease. Neurology 2016;87:521–58 doi:10.1212/WNL.0000000000002917 pmid:27371488

   Abstract/FREE Full Text
8. 8.↵
   1. Irani SR,
   2. Alexander S,
   3. Waters P, et al

   . Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 2010;133:2734–48 doi:10.1093/brain/awq213 pmid:20663977

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Malter MP,
   2. Frisch C,
   3. Schoene-Bake JC, et al

   . Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 2014;261:1695–705 doi:10.1007/s00415-014-7408-6 pmid:24935858

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Jayaweera HK,
    2. Hickie IB,
    3. Duffy SL, et al

    . Episodic memory in depression: the unique contribution of the anterior caudate and hippocampus. Psychol Med 2016;46:2189–99 doi:10.1017/S0033291716000787 pmid:27150660

    CrossRefPubMed
11. 11.↵
    1. Finke C,
    2. Kopp UA,
    3. Scheel M, et al

    . Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2013;74:284–96 doi:10.1002/ana.23932 pmid:23686722

    CrossRefPubMed
12. 12.↵
    1. Wagner J,
    2. Schoene-Bake JC,
    3. Witt JA, et al

    . Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis. Epilepsia 2016;57:475–83 doi:10.1111/epi.13297 pmid:26749370

    CrossRefPubMed
13. 13.↵
    1. Heine J,
    2. Prüss H,
    3. Bartsch T, et al

    . Imaging of autoimmune encephalitis; relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68–83 doi:10.1016/j.neuroscience.2015.05.037 pmid:26012492

    CrossRefPubMed
14. 14.↵
    1. Urbach H,
    2. Rauer S,
    3. Mader I, et al

    . Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis. Neuroradiology 2015;57:1203–09 doi:10.1007/s00234-015-1581-x pmid:26293130

    CrossRefPubMed
15. 15.↵
    1. Wagner J,
    2. Weber B,
    3. Elger CE.

    Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry. Epilepsia 2015;56:754–61 doi:10.1111/epi.12968 pmid:25809952

    CrossRefPubMed
16. 16.↵
    1. Malter MP,
    2. Frisch C,
    3. Zeitler H, et al

    . Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 2015;30:57–63 doi:10.1016/j.seizure.2015.05.017 pmid:26216686

    CrossRefPubMed
17. 17.↵
    1. Gastaldi M,
    2. Thouin A,
    3. Vincent A.

    Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurothera-peutics 2016;13:147–62 doi:10.1007/s13311-015-0410-6 pmid:26692392

    CrossRefPubMed
18. 18.↵
    1. Fischl B,
    2. Salat DH,
    3. Busa E, et al

    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/S0896-6273(02)00569-X pmid:11832223

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Fischl B,
    2. Salat DH,
    3. Van Der Kouwe AJW, et al

    . Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004;23(Suppl 1):S69–84 doi:10.1016/j.neuroimage.2004.07.016 pmid:15501102

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Iglesias JE,
    2. Augustinack JC,
    3. Nguyen K, et al

    . A computational atlas of the hippocampal formation using ex vivo, ultra-high-resolution MRI: application to adaptive segmentation of in vivo MRI. Neuroimage 2015;115:117–37 doi:10.1016/j.neuroimage.2015.04.042 pmid:25936807

    CrossRefPubMed
21. 21.↵
    1. Milliken GA,
    2. Johnson DE.

    Analysis of Messy Data. London: Chapman & Hall/CRC; 2009
22. 22.↵
    1. Pedregosa F,
    2. Weiss R,
    3. Brucher M.

    Scikit-Learn: machine learning in Python. https://scikit-learn.org/stable/index.html. Accessed February 4, 2019
23. 23.↵
    1. Quinlan JR.

    Induction of decision trees. Mach Learning 1986;1:81–106 doi:10.1007/BF00116251

    CrossRef
24. 24.↵
    1. Finke C,
    2. Prüss H,
    3. Heine J, et al

    . Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 2017;74:50–59 doi:10.1001/jamaneurol.2016.4226 pmid:27893017

    CrossRefPubMed
25. 25.↵
    1. Wagner J,
    2. Witt JA,
    3. Helmstaedter C, et al

    . Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2015;86:735–42 doi:10.1136/jnnp-2014-307875 pmid:25185210

    Abstract/FREE Full Text
26. 26.↵
    1. Urbach H,
    2. Soeder BM,
    3. Jeub M, et al

    . Serial MRI of limbic encephalitis. Neuroradiology 2006;48:380–86 doi:10.1007/s00234-006-0069-0 pmid:16586118

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Bartsch T,
    2. Döhring J,
    3. Reuter S, et al

    . Selective neuronal vulnerability of human hippocampal CA1 neurons: lesion evolution, temporal course, and pattern of hippocampal damage in diffusion-weighted MR imaging. J Cereb Blood Flow Metab 2015;35:1836–45 doi:10.1038/jcbfm.2015.137 pmid:26082014

    CrossRefPubMed
28. 28.↵
    1. Irani SR,
    2. Stagg CJ,
    3. Schott JM, et al

    . Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013;136:3151–62 doi:10.1093/brain/awt212 pmid:24014519

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Navarro V,
    2. Kas A,
    3. Apartis E, et al

    . Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 2016;139:1079–93 doi:10.1093/brain/aww012 pmid:26945884

    CrossRefPubMed
30. 30.↵
    1. Khan NL,
    2. Jeffree MA,
    3. Good C, et al

    . Histopathology of VGKC antibody-associated limbic encephalitis. Neurology 2009;72:1703–05 doi:10.1212/WNL.0b013e3181a55eb3 pmid:19433746

    FREE Full Text
31. 31.↵
    1. Graus F,
    2. Saiz A,
    3. Lai M, et al

    . Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008;71:930–36 doi:10.1212/01.wnl.0000325917.48466.55 pmid:18794496

    Abstract/FREE Full Text
32. 32.↵
    1. Bartsch T,
    2. Alfke K,
    3. Stingele R, et al

    . Selective affection of hippocampal CA-1 neurons in patients with transient global amnesia without long-term sequelae. Brain 2006;129:2874–84 doi:10.1093/brain/awl248 pmid:17003071

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Bartsch T,
    2. Dohring J,
    3. Rohr A, et al

    . CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness. Proc Natl Acad Sci U S A 2011;108:17562–67 doi:10.1073/pnas.1110266108 pmid:21987814

    Abstract/FREE Full Text
34. 34.↵
    1. Witt JA,
    2. Vogt VL,
    3. Widman G, et al

    . Loss of autonoetic awareness of recent autobiographical episodes and accelerated long-term forgetting in a patient with previously unrecognized glutamic acid decarboxylase antibody related limbic encephalitis. Front Neurol 2015;6:1–8 doi:10.3389/fneur.2015.00130 pmid:26106363

    CrossRefPubMed
35. 35.↵
    1. Schmidt-Kastner R,
    2. Freund TF.

    Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991;40:599–636 doi:10.1016/0306-4522(91)90001-5 pmid:1676492

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Butler TR,
    2. Self RL,
    3. Smith KJ, et al

    . Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-d-asparate-type glutamate receptors. Neuroscience 2010;165:525–34 doi:10.1016/j.neuroscience.2009.10.018 pmid:19837138

    CrossRefPubMed
37. 37.↵
    1. Lalonde CC,
    2. Mielke JG.

    Selective vulnerability of hippocampal sub-fields to oxygen-glucose deprivation is a function of animal age. Brain Res 2014;1543:271–79 doi:10.1016/j.brainres.2013.10.056 pmid:24211659

    CrossRefPubMed
38. 38.↵
    1. Vos de Wael R,
    2. Larivière S,
    3. Caldairou B, et al

    . Anatomical and microstructural determinants of hippocampal subfield functional connectome embedding. Proc Natl Acad Sci USA 2018;115:10154–59 doi:10.1073/pnas.1803667115 pmid:30249658

    Abstract/FREE Full Text
39. 39.↵
    1. Zeidman P,
    2. Maguire EA.

    Anterior hippocampus: the anatomy of perception, imagination and episodic memory. Nat Rev Neurosci 2016;17:173–82 doi:10.1038/nrn.2015.24 pmid:26865022

    CrossRefPubMed
40. 40.↵
    1. Varoquaux G.

    Cross-validation failure: small sample sizes lead to large error bars. Neuroimage 2018;180:68–77 doi:10.1016/j.neuroimage.2017.06.061 pmid:28655633

    CrossRefPubMed